SCHEMBL6499094

SCHEMBL6499094

CSc1ccc(C=CC(=O)N2CCC(C(=O)NC(CC(C)C)C(=O)O)CC2)c(Cl)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.54
ITGAL P20701 10/20 0.53
ITGB2 P05107 9/20 0.53
ICAM1 P05362 9/20 0.53
MAPK1 P28482 1/20 0.42
PSMB11 A5LHX3 1/20 0.38
PSMA7 O14818 1/20 0.38
PSMB1 P20618 1/20 0.38
PSMA1 P25786 1/20 0.38
PSMA2 P25787 1/20 0.38
PSMA3 P25788 1/20 0.38
PSMA4 P25789 1/20 0.38
PSMB8 P28062 1/20 0.38
PSMB9 P28065 1/20 0.38
PSMA5 P28066 1/20 0.38
PSMB4 P28070 1/20 0.38
PSMB6 P28072 1/20 0.38
PSMB5 P28074 1/20 0.38
PSMB10 P40306 1/20 0.38
PSMB3 P49720 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6499090 1.00 CAPN1 (0.54) CAPN1ITGALITGB2ICAM1MAPK1
SCHEMBL6497014 0.93 ITGAL (0.51) CAPN1ITGALITGB2ICAM1MAPK1
SCHEMBL8298637 0.91 CAPN1 (0.53) CAPN1ITGALITGB2ICAM1MAPK1
SCHEMBL6499198 0.91 CAPN1 (0.53) CAPN1ITGALITGB2ICAM1NPC1
SCHEMBL6499199 0.91 CAPN1 (0.53) CAPN1ITGALITGB2ICAM1NPC1
SCHEMBL8296816 0.91 CAPN1 (0.53) CAPN1ITGALITGB2ICAM1NPC1
SCHEMBL8298602 0.90 ITGAL (0.51) CAPN1ITGALITGB2ICAM1NPC1
SCHEMBL6497397 0.90 ITGAL (0.51) CAPN1ITGALITGB2ICAM1NPC1
SCHEMBL6497403 0.90 ITGAL (0.51) CAPN1ITGALITGB2ICAM1NPC1
SCHEMBL6497008 0.89 ITGB2 (0.50) CAPN1ITGALITGB2ICAM1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO claimed
WO-2005016883-A2 ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF ICOS CORPORATION (US) 2005-02-24 WO disclosed